Consolidated Statement Of Cash Flows

Kubota Pharmaceutical Holdings Co., Ltd. - Filing #7271008

Concept 2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
As at
2024-12-31
2024-01-01 to
2024-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
As at
2023-12-31
2023-01-01 to
2023-12-31
As at
2022-12-31
Consolidated statement of cash flows
Statement of cash flows
Cash flows from operating activities
Profit (loss)
-1,332,852,000 JPY
-1,332,852,000 JPY
-1,332,852,000 JPY
-1,489,602,000 JPY
-1,489,602,000 JPY
-1,489,602,000 JPY
Impairment losses (reversal of impairment losses)
56,376,000 JPY
110,495,000 JPY
Finance income
-5,727,000 JPY
-13,907,000 JPY
Finance costs
7,402,000 JPY
9,374,000 JPY
Subtotal
-1,187,664,000 JPY
-1,326,659,000 JPY
Interest paid
-7,411,000 JPY
-9,280,000 JPY
Net cash provided by (used in) operating activities
-1,195,075,000 JPY
-1,335,939,000 JPY
Cash flows from investing activities
Purchase of property, plant and equipment
-49,735,000 JPY
-66,287,000 JPY
Net cash provided by (used in) investing activities
-43,057,000 JPY
-45,033,000 JPY
Cash flows from financing activities
Net cash provided by (used in) financing activities
-88,273,000 JPY
96,581,000 JPY
Cash and cash equivalents
1,454,908,000 JPY
2,767,639,000 JPY
4,048,969,000 JPY
Effect of exchange rate changes on cash and cash equivalents
13,674,000 JPY
3,061,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.